Biochemical analysis of microbiotas obtained from healthy, prediabetic, type 2 diabetes, and obese individuals
Author:
Düzgün Çağla1ORCID, Dede Süreyya1ORCID, Karakuş Emine1ORCID, Adaş Mine2ORCID, Bilen Ömer3ORCID
Affiliation:
1. Department of Chemistry, Faculty of Arts and Sciences , Yildiz Technical University , Istanbul , Türkiye 2. Endocrinology and Metabolic Diseases Clinic , University of Health Sciences Okmeydanı Training and Research Hospital , Istanbul , Türkiye 3. Department of Urban and Regional Planning, Faculty of Architecture and Design , Bursa Technical University , Bursa , Türkiye
Abstract
Abstract
Objectives
In this study, we aimed to evaluate the intestinal and urinary microbiota diversity of obese, pre-diabetic, diabetic, and healthy subjects together with their food consumption frequency and investigate the effect on glucose metabolism.
Methods
DNA was isolated from stool and urinary samples of fifteen obese, fifteen prediabetics, fifteen type 2 diabetic, and fifteen lean participants by using the quantitative real-time polymerase chain reaction (qPCR) method. The amounts of Bifidobacterium, Bacteroides, and Firmicutes were measured and food consumption frequency was answered by all participants through a questionnaire.
Results
The levels of Bifidobacterium in fecal microbiota were significantly higher in type 2 diabetic patients compared with lean (p=0.034), prediabetic (p=0.009), and obese participants (p=0.012). However, the levels of Bifidobacterium in urinary microbiota were decreased in obese, prediabetic, and type 2 diabetic subjects as controls (p=0.048; p=0.038; p=0.015 respectively). Additionally, Bacteroides/Firmicutes ratio decreased in type two diabetic patients compared with lean subjects and had a negative correlation with BMI in prediabetic subjects. Food consumption frequency illustrates that lean subjects have unhealthy eating habits.
Conclusions
Urinary microbiota could be considered in the future context of a potential biomarker in the progress of type 2 diabetes and obesity.
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,Molecular Biology,Biochemistry
Reference31 articles.
1. Larsen, N, Vogensen, FK, Van Den Berg, FW, Nielsen, DS, Andreasen, AS, Pedersen, BK, et al.. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010;5:e9085. https://doi.org/10.1371/journal.pone.0009085. 2. Salas-Salvadó, J, Guasch-Ferre, M, Díaz-López, A, Babio, N. Yogurt and diabetes: overview of recent observational studies. J Nutr 2017;147:1452S–61S. https://doi.org/10.3945/jn.117.248229. 3. Andoh, A, Nishida, A, Takahashi, K, Inatomi, O, Imaeda, H, Bamba, S, et al.. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population. J Clin Biochem Nutr 2016;59:65–70. https://doi.org/10.3164/jcbn.15-152. 4. Remely, M, Dworzak, S, Hippe, B, Zwielehner, J, Aumüller, E, Brath, H, et al.. Abundance and diversity of microbiota in type 2 diabetes and obesity. J Diabetes Metabol 2013;4:2. https://doi.org/10.4172/2155-6156.1000253. 5. Muñoz-Garach, A, Diaz-Perdigones, C, Tinahones, JF. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr 2016;63:560–8. https://doi.org/10.1016/j.endoen.2016.07.004.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|